Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): Results of a prospective, single-arm multicentre study

A. Cortelezzi, M. C. Pasquini, A. Gardellini, U. Gianelli, A. Bossi, G. Reda, B. Sarina, P. Musto, W. Barcellini, A. Neri, G. L. Deliliers

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): Results of a prospective, single-arm multicentre study'. Together they form a unique fingerprint.

Medicine & Life Sciences